Largest biotech companies by cash on hand

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Amgen leads the 24 biotech companies ranked by cash on hand, at R$53.5B, ahead of BioNTech (R$49.9B) and Gilead Sciences (R$44.4B). Figures as of 18 Nov 2026, 19:53 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
AmgenR$53.5B
Median
R$2.5B
Combined market value
R$4.91T
Countries
5

Market values as of .

All countries
All sectors
Biotech
BRL
Clear filters
Largest biotech companies by cash on hand
#CompanyCash on hand ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareR$53.5BR$1.41TR$2,601.02 3.14% down 34% up United States
2BioNTechBNTX · Health CareR$49.9BR$121.4BR$489.68 1.60% down 16% down Germany
3Gilead SciencesGILD · Health CareR$44.4BR$1.23TR$992.09 0.63% down 33% up United States
4argenxARGX · Health CareR$20.5BR$348.1BR$5,535.36 0.38% down 4% up Belgium
5BiogenBIIB · Health CareR$17.6BR$216.9BR$1,467.29 0.23% down 49% up United States
6ModernaMRNA · Health CareR$15.2BR$470.8BR$1,163.55 4.05% down 755% up United States
7ImmunovantIMVT · Health CareR$5.3BR$40.4BR$195.04 0.15% up 43% up United States
8QiagenQGEN · Health CareR$4.9BR$60BR$290.77 0.33% down 12% up Netherlands
9Neurocrine BiosciencesNBIX · Health CareR$4.2BR$97.2BR$959.81 1.35% down 20% up United States
10RepligenRGEN · Health CareR$3.3BR$64.2BR$1,004.99 5.67% up 5% up United States
11Krystal BiotechKRYS · Health CareR$2.9BR$54.6BR$1,843.44 5.30% up 46% up United States
12ExelixisEXEL · Health CareR$2.8BR$98.2BR$402.57 0.22% up 63% up United States
13Revolution MedicinesRVMD · Health CareR$2.3BR$203.5BR$940.78 1.39% down 131% up United States
14Kymera TherapeuticsKYMR · Health CareR$2.1BR$60.7BR$711.20 0.20% down 87% up United States
15CRISPR TherapeuticsCRSP · Health CareR$2BR$23.2BR$239.20 1.59% up 21% down Switzerland
16Scholar Rock HoldingSRRK · Health CareR$1.9BR$34BR$278.90 5.50% up 14% up United States
17Bio-TechneTECH · Health CareR$1.6BR$67BR$426.79 0.21% up 26% up United States
18Kodiak SciencesKOD · Health CareR$1.2BR$37.2BR$568.76 0.20% up 396% up United States
19Twist BioscienceTWST · Health CareR$1.1BR$46.6BR$682.82 3.96% up 340% up United States
20VaxcytePCVX · Health CareR$1BR$54.3BR$342.82 1.58% down 22% up United States
21Halozyme TherapeuticsHALO · Health CareR$784.7MR$64.3BR$564.24 0.26% up 37% up United States
22ImmunityBioIBRX · Health CareR$518MR$41.9BR$39.38 7.27% up 193% up United States
23Adaptive BiotechnologiesADPT · Health CareR$413.4MR$27BR$166.57 0.30% down 88% up United States
24CG OncologyCGON · Health CareR$190.5MR$42.1BR$471.30 1.81% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 5.8641 BRL).

Questions and answers

Which biotech companies rank first by cash on hand?

Amgen (R$53.5B), BioNTech (R$49.9B) and Gilead Sciences (R$44.4B) are the top three of the 24 biotech companies ranked by cash on hand as of 18 Nov 2026, 19:53 UTC.

How many biotech companies are in this ranking?

24 are ranked by cash on hand.

What are these biotech companies worth together?

The 24 biotech companies ranked by cash on hand have a combined market value of R$4.91T as of 18 Nov 2026, 19:53 UTC.

What does ranking by cash on hand measure?

Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.

Cite this page

Funkfolio, “Largest biotech companies by cash on hand”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=cash-on-hand

Underlying data: Yahoo Finance; SEC EDGAR.